{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:23:57Z","timestamp":1777433037221,"version":"3.51.4"},"reference-count":18,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Australas Psychiatry"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Guidelines stipulate that baseline prolactin be ordered prior to commencing antipsychotic treatment to facilitate investigation of any subsequent hyperprolactinaemic symptoms. The aim was to observe when and why prolactin levels are ordered for psychiatry inpatients commencing or continuing antipsychotics and how this alters clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Psychiatry inpatients admitted to the Alfred Hospital, Melbourne, Australia, in 2018 with the diagnoses of psychosis, schizophrenia, schizo-affective disorder or bipolar affective disorder were retrospectively analysed. Results and clinical history data were collected in patients in whom prolactin was ordered during or within 12 months of the relevant admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 592 patients admitted during this period, 90 had prolactin ordered. Eight (8.9%) of the 90 tests were for hyperprolactinaemic symptoms, while the remainder were routine blood work. The results altered clinical management in 10 of the 90 (11.1%) patients. Of these 10, 8 were symptomatic. In the six patients with first episode psychosis, only one had prolactin ordered prior to antipsychotic commencement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Adherence to guideline recommendations of baseline prolactin testing was poor. When established on antipsychotics, measuring prolactin rarely changed management in asymptomatic patients; however, it did in those with hyperprolactinaemic symptoms. Measuring prolactin in asymptomatic patients on antipsychotics appears unhelpful.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1039856220934326","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T20:26:36Z","timestamp":1593116796000},"page":"282-285","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Prolactin ordering patterns in psychiatric inpatients and the impact this has on patient management"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-0220","authenticated-orcid":false,"given":"Annabel S","family":"Jones","sequence":"first","affiliation":[{"name":"Department of Endocrinology & Diabetes, Alfred Hospital, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana","family":"Sztal-Mazer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Diabetes, Alfred Hospital, Australia"},{"name":"Central Clinical School, Monash University, Australia"},{"name":"Women\u2019s Health Research Program, School of Public Health and Preventive Medicine, Monash University, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-6828","authenticated-orcid":false,"given":"Ilan","family":"Rauchberger","sequence":"additional","affiliation":[{"name":"Adult Inpatient Psychiatry Unit, Alfred Mental and Addiction Health, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Shane","family":"Hamblin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Diabetes, Alfred Hospital, Australia"},{"name":"Department of Medicine - Western Precinct, University of Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"bibr1-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1692"},{"key":"bibr2-1039856220934326","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464200-00003"},{"key":"bibr3-1039856220934326","first-page":"929","volume":"3","author":"Torre D","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"bibr4-1039856220934326","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1108"},{"key":"bibr5-1039856220934326","volume":"28","author":"Peuskens J","year":"2014","journal-title":"CNS Drugs"},{"key":"bibr6-1039856220934326","doi-asserted-by":"publisher","DOI":"10.3109\/00048674.2011.589044"},{"key":"bibr7-1039856220934326","unstructured":"Melmed S, Kleinberg D. Anterior pituitary. In: Kronenberg HM, Melmed S, Polonsky KS, et al. (eds) Williams Textbook of Endocrinology. 11th ed. Philadelphia: Saunders Elsevier, 2008, pp.185\u2013261."},{"key":"bibr8-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02562.x"},{"key":"bibr9-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197703172961103"},{"key":"bibr10-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346388"},{"key":"bibr11-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-2-412"},{"key":"bibr12-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)59292-9"},{"key":"bibr13-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.1.64"},{"key":"bibr14-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200204000-00002"},{"key":"bibr15-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107087951"},{"key":"bibr16-1039856220934326","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107086516"},{"key":"bibr17-1039856220934326","unstructured":"National Institute for Health and Care Excellence, Psychosis and Schizophrenia in adults: prevention and management: Clinical Guideline, February 2014, Updated March 2014."},{"key":"bibr18-1039856220934326","unstructured":"Australian Institute of Health and Welfare 2019. Australian refined diagnosis-related groups(AR-DRG) data cubes. Canberra: AIHW. Viewed 17 April 2020, https:\/\/www.aihw.gov.au\/reports\/hospitals\/ar-drg-data-cubes"}],"container-title":["Australasian Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1039856220934326","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1039856220934326","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1039856220934326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:50:28Z","timestamp":1777377028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1039856220934326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1177\/1039856220934326"],"URL":"https:\/\/doi.org\/10.1177\/1039856220934326","relation":{},"ISSN":["1039-8562","1440-1665"],"issn-type":[{"value":"1039-8562","type":"print"},{"value":"1440-1665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]}}}